Siemens AG, Europe’s biggest engineering company, will buy a 16 percent stake in a medical equipment venture with drugmaker Mochida Pharmaceutical Co., giving it a majority holding, Mochida announced Monday.
After the Oct. 1 transaction, Siemens will hold 51 percent of the venture, with the remainder owned by Mochida. The venture has 130 employees and generated revenue of ¥5.6 billion in its last business year. Mochida said the transaction will have little impact on earnings this year.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.